Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Why Are ISRG Shares Falling Today?

This morning we watched Intuitive Surgical drop -3.9% to a price of $584.86 per share. The Large-Cap Specialty Industrial Machinery company is now trading -6.25% below its average target price of $623.87. Analysts have set target prices ranging from $350.0 to $711.0 per share for Intuitive Surgical, and have given the stock an average rating of buy.

Intuitive Surgical's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.2%. The stock's short ratio is 3.39. The company's insiders own 0.52% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 89.3%. In conclusion, we believe there is mixed market sentiment regarding Intuitive Surgical.

Institutions Invested in Intuitive Surgical

Date Reported Holder Percentage Shares Value
2024-09-30 Vanguard Group Inc 9% 31,851,605 $18,628,729,233
2024-09-30 Blackrock Inc. 8% 30,190,103 $17,656,983,198
2024-09-30 State Street Corporation 4% 15,050,121 $8,802,213,547
2024-09-30 Price (T.Rowe) Associates Inc 4% 14,595,436 $8,536,286,485
2024-09-30 FMR, LLC 3% 10,971,085 $6,416,548,612
2024-09-30 JP Morgan Chase & Company 3% 9,998,618 $5,847,791,577
2024-09-30 Geode Capital Management, LLC 2% 7,512,925 $4,394,009,205
2024-09-30 Capital World Investors 2% 7,414,450 $4,336,415,118
2024-09-30 Morgan Stanley 2% 5,581,412 $3,264,344,540
2024-09-30 Bank Of New York Mellon Corporation 2% 5,388,903 $3,151,753,729
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS